|
注册号: Registration number: |
ChiCTR2600122509 |
|
最近更新日期: Date of Last Refreshed on: |
2026-04-14 16:09:47 |
|
注册时间: Date of Registration: |
2026-04-14 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
老年髋部骨折手术时机对患者临床结局影响的观察性研究 |
|
Public title: |
Observational Study on the Impact of Surgical Timing on Clinical Outcomes in Elderly Patients with Hip Fractures |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
老年髋部骨折手术时机对患者临床结局影响的观察性研究 |
|
Scientific title: |
Observational Study on the Impact of Surgical Timing on Clinical Outcomes in Elderly Patients with Hip Fractures |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
张慧星 |
研究负责人: |
陈国忠 |
|
Applicant: |
Zhang Huixing |
Study leader: |
Chen Guozhong |
|
申请注册联系人电话: Applicant telephone: |
+86 21 5560 3999 |
研究负责人电话:
Study leader's |
+86 21 5560 3999 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
zhanghx_165@163.com |
研究负责人电子邮件: Study leader's E-mail: |
zhanghx_165@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
上海市虹口区三门路1279号 |
研究负责人通讯地址: |
上海市虹口区三门路1279号 |
|
Applicant address: |
No. 1279, Sanmen Road, Hongkou District, Shanghai |
Study leader's address: |
No. 1279, Sanmen Road, Hongkou District, Shanghai |
|
申请注册联系人邮政编码: Applicant postcode: |
200434 |
研究负责人邮政编码: Study leader's postcode: |
200434 |
|
申请人所在单位: |
同济大学附属上海市第四人民医院 |
||
|
Applicant's institution: |
Shanghai Fourth People's Hospital Affiliated to Tongji University |
||
|
研究负责人所在单位: |
同济大学附属上海市第四人民医院 |
||
|
Affiliation of the Leader: |
Shanghai Fourth People's Hospital Affiliated to Tongji University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2026016-001 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
上海市第四人民医院医学伦理委员会 |
||
|
Name of the ethic committee: |
The Medical Ethics Committee of the Fourth People's Hospital of Shanghai Municipality |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2026-03-11 00:00:00 | ||
|
伦理委员会联系人: |
陈辉 |
||
|
Contact Name of the ethic committee: |
Chen Hui |
||
|
伦理委员会联系地址: |
上海市虹口区三门路1279号 |
||
|
Contact Address of the ethic committee: |
No. 1279, Sanmen Road, Hongkou District, Shanghai |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 21 5560 3999 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
shsylunli@163.com |
|
研究实施负责(组长)单位: |
同济大学附属上海市第四人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Shanghai Fourth People's Hospital Affiliated to Tongji University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
上海市虹口区三门路1279号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 1279, Sanmen Road, Hongkou District, Shanghai |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
Self-funding |
||||||||||||||||||||||
|
研究疾病: |
髋部骨折 |
||||||||||||||||||||||
|
Target disease: |
Hip fracture |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
连续入组 |
||||||||||||||||||||||
|
Study design: |
Sequential |
||||||||||||||||||||||
|
研究目的: |
观察老年髋部骨折手术时机对患者临床结局的影响,通过患者术前、术中及术后数据的综合分析,总结影响老年髋部骨折手术结局的主要因素。 基于老年髋部骨折手术患者的术前(合并症、营养状况、基础疾病治疗用药等)、术中(出血、血压波动等)及术后(循环、呼吸、神经、泌尿等系统并发症)全流程数据,综合分析老年髋部骨折患者不同手术时机下手术麻醉管理与患者结局的关联,总结影响患者主要并发症(呼吸系统疾病、谵妄、深静脉血栓等,需要临床干预的并发症)住院死亡率的核心因素。 |
||||||||||||||||||||||
|
Objectives of Study: |
To observe the impact of the timing of hip fracture surgery in the elderly on the clinical outcomes of patients, through a comprehensive analysis of the preoperative, intraoperative and postoperative data of the patients, summarize the main factors influencing the surgical outcomes of hip fractures in the elderly. Based on the preoperative (comorbidities, nutritional status, treatment of underlying diseases, etc.), intraoperative (bleeding, blood pressure fluctuations, etc.) and postoperative (circulatory, respiratory, nervous, urinary and other system complications) full-process data of elderly patients undergoing hip fracture surgery, conduct a comprehensive analysis of the association between surgical anesthesia management and patient outcomes under different surgical timing, and summarize the core factors influencing the in-hospital mortality rate of major complications (respiratory system diseases, delirium, deep vein thrombosis, etc., complications that require clinical intervention). |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1.病理性骨折(如肿瘤转移、骨质疏松性重度病理性骨折)、陈旧性髋部骨折(伤后超过2周); 2.合并严重凝血功能障碍(如血友病、严重肝病致凝血因子缺乏)、严重感染性疾病(如败血症、感染性休克)、终末期脏器功能衰竭(心、肝、肾、脑功能衰竭); 3.认知功能完全丧失或无法配合随访评估的患者; 4.中途转院、自动出院或术后30天内失访的患者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Pathological fractures (such as tumor metastasis, severe pathological fractures due to osteoporosis), old hip fractures (occurring more than 2 weeks after injury); 2. Complicated with severe coagulation dysfunction (such as hemophilia, severe liver disease resulting in deficiency of coagulation factors), severe infectious diseases (such as sepsis, septic shock), end-stage organ failure (heart, liver, kidney, brain failure); 3. Patients with complete loss of cognitive function or unable to cooperate with follow-up assessment; 4. Patients who were transferred to another hospital halfway, automatically discharged, or lost follow-up within 30 days after surgery. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2026-03-12 00:00:00至 To 2027-04-12 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2026-04-15 00:00:00 至 To 2027-03-12 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form, CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |